🇺🇸 FDA
Pipeline program

ATORVASTATIN, PLACEBO

Approved small_molecule active

Quick answer

ATORVASTATIN, PLACEBO for Atherosclerosis is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Atherosclerosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials